BlackRock »

Moonlake Immunot shares owned by BlackRock

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $20M 401k 50.42

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
T. Rowe Price Associates
Citadel Advisors
Holocene Advisors
Goldman Sachs Group
Westfield Capital Management Company
Marshall Wace
Federated Investors
Alliancebernstein
Paradigm Biocapital Advisors
Logos Global Management
Fred Alger Management
Balyasny Asset Management
Nuveen Asset Management

View all funds holding Moonlake Immunot